How much does it cost per month for patients to be treated with evantumumab
Amivantumab (amivantamab-vmjw), a bispecific antibody targeting EGF and MET receptors, has demonstrated efficacy in the treatment of non-small cell lung cancer. For patients, in addition to being concerned about the therapeutic effects of drugs, the cost of treatment is also an important consideration. So, how much does one month of evantuzumab treatment cost?
First understand the dosage regimen of evantumumab. Dosage and frequency may be adjusted based on the patient's weight and treatment regimen. Generally speaking, the dosage of medication is different for patients weighing less than 80Kg and for patients weighing 80Kg or more.
During treatment, evantumumab can be used alone or in combination with other drugs. When used in combination, patients weighing less than 80Kg should be injected once a week for the first four weeks, with each dose being 1400mg; patients weighing 80Kg or more should be injected once a week for the first four weeks, but each dose is increased to 1750mg. Starting in the seventh week, the frequency of injections was changed to once every three weeks, and the dosage was also adjusted. When evantumumab is used alone, the dosage regimen and dosage will be different.
Regarding fees. The current price of the European version of the original drug sold overseas may be around RMB 20,000 (the price may fluctuate due to exchange rates). Therefore, the cost of one month of evantumumab treatment depends on the patient's weight and treatment regimen. Generally speaking, the monthly cost may be more than 10,000 yuan. But this is only a rough estimate, and actual costs may vary depending on factors such as region, hospital, and insurance status.
In general, the cost of evantumumab treatment varies from person to person and needs to be determined based on the patient's condition. When patients choose treatment options, in addition to considering the efficacy of the drug, they also need to make decisions based on their own financial situation.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)